immun
system
consist
variou
key
line
defenc
innat
natur
unspecif
immun
lack
specif
memori
organ
front
line
defenc
compon
alway
present
readi
go
immedi
action
without
need
latent
period
trigger
respons
acquir
adapt
specif
immun
also
known
immunitari
respons
much
complex
unspecif
immun
characteris
adapt
antigen
specif
memori
acquir
immun
identifi
specif
pathogen
peptid
present
antigenpres
cell
turn
activ
cellular
humor
immunitari
respons
mediat
cellular
b
humor
cell
effici
immunitari
respons
depend
interact
innat
acquir
immun
system
immunitari
respons
characteris
separ
field
immunolog
focu
centr
mainli
knowledg
acquir
immun
nevertheless
natur
immun
system
mammal
yet
adequ
characteris
activ
innat
immunitari
system
constitut
crucial
step
develop
specif
acquir
immun
antigen
primari
respons
pathogen
innat
immunitari
system
mediat
pattern
recognit
receptor
prr
recognis
pathogenassoci
molecular
pattern
pamp
present
wide
array
microorgan
import
prr
tolllik
receptor
tlr
select
recognis
larg
number
vari
complex
pamp
characterist
molecul
microorgan
lipopolysaccharid
flagellin
mannos
nucleic
acid
viru
bacteria
prr
particular
tlr
recognis
microorganismspecif
molecul
innat
immun
respons
trigger
activ
product
inflammatori
mediat
larg
number
interleukin
il
interferon
ifn
tumour
necrosi
factoralpha
toward
end
toll
receptor
identifi
one
key
receptor
involv
defenc
innat
immun
respons
drosophila
fungal
infect
one
year
later
shown
homolog
mammal
toll
receptor
would
induc
inflammatori
gene
express
date
approxim
tlr
indentifi
mammal
human
function
tlr
describ
tlr
type
transmembran
protein
includ
multipl
copi
leucinerich
repeat
lrr
extracellular
domain
intracellular
signal
domain
share
toll
receptor
receptor
call
tir
receptor
figur
tir
domain
abil
bind
activ
distinct
molecul
among
myeloid
differenti
factor
domaincontain
adaptor
protein
tirap
domaincontain
adaptor
induc
ifnbeta
trif
trifrel
adaptor
molecul
tram
receptorassoci
kinas
irak
tumour
necrosi
factor
tnf
tnf
receptorassoci
factor
necessari
activ
differ
pathway
mitogenactiv
protein
kinas
map
signal
transduc
activ
transcript
stat
nuclear
factorkappa
b
pathway
express
cellular
surfac
migrat
phagosom
membranebound
vesicl
phagocyt
form
inward
fold
cell
membran
phagocytis
materi
activ
recognis
ligand
express
intracellular
compart
mainli
endosom
endoplasm
reticulum
tlr
recognis
group
characterist
molecul
tlr
express
cellular
membran
recognis
molecul
lipoprotein
gramposit
bacteria
associ
lipopolysaccharid
gramneg
bacteria
flagellin
bacteri
flagella
infect
rna
viru
respiratori
syncyti
viru
influenza
major
caus
inflamm
airway
tlr
express
intracellular
compart
recognis
nucleic
acid
viru
thu
detect
intracellular
infect
tabl
figur
recognit
ligand
tlr
present
dendrit
macrophag
cell
lead
rapid
product
cytokin
chemokin
indic
presenc
pathogen
respons
initi
rapid
recruit
cell
immun
system
site
infect
activ
launch
immedi
respons
pathogen
signal
origin
tlr
promot
express
adher
molecul
epitheli
cell
well
circul
haematopoiet
cell
among
antigenpres
cell
process
present
antigen
fuse
molecul
main
class
ii
histocompat
complex
monocytesmacrophag
dendrit
cell
b
cell
cell
particular
dendrit
cell
form
interfac
type
respons
innat
acquir
tlr
ligand
caus
cell
matur
becom
activ
recognit
ligand
eg
lipopolysaccharid
lp
activ
tlr
recruit
myeloid
differenti
factor
interact
tlr
tir
toll
receptor
turn
interact
irak
receptorassoci
kinas
signal
transduct
factor
tnf
receptorassoci
factor
stimul
irak
carri
signal
seri
phosphoril
nuclear
factor
final
activ
appropri
gene
transcript
immun
respons
antigenpres
cell
induc
express
costimul
molecul
necessari
activ
lymphocyt
mani
tlrinduc
il
guid
differenti
cell
helper
lymphocyt
cytotox
lymphocyt
lymphocyt
stimul
produc
tnf
control
use
cellular
immun
reaction
infect
microorgan
intracellular
growth
lymphocyt
stimul
produc
collabor
humor
immun
reaction
fundament
neutralis
toxin
infect
germ
extracellular
growth
type
lymphocyt
regul
import
develop
control
immunitari
respons
mention
earlier
type
tlr
identifi
mammal
human
mice
equival
form
isol
mammalian
speci
nevertheless
tlr
found
human
present
mammal
convers
mammal
may
express
tlr
isol
human
exampl
express
mice
moment
function
tlr
describ
human
circumst
condit
limit
use
experiment
anim
innat
immun
model
extrapol
human
speci
princip
characterist
human
tlr
shown
tabl
allerg
diseas
like
asthma
rhiniti
atop
dermat
constitut
group
high
preval
process
suscept
develop
influenc
multipl
genet
environment
factor
varieti
conclus
evid
indic
exposur
microbi
product
infanc
play
import
role
postnat
matur
immun
system
hypothes
rise
preval
allerg
diseas
industrialis
countri
last
year
could
relat
reduct
microbi
load
geograph
area
hypothesi
known
hygien
hypothesi
base
observ
develop
countri
invers
relat
increas
allerg
diseas
reduct
microbi
exposur
first
stage
life
lead
defect
organ
immun
regul
discoveri
tlr
action
provid
immunolog
basi
studi
hygien
hypothesi
today
still
mani
unansw
question
aetiolog
pathogenesi
phenotyp
asthma
exampl
well
differenti
type
asthma
allerg
extrins
nonallerg
intrins
allerg
asthma
characteris
affect
larg
part
children
young
adult
person
famili
histori
allergi
rhiniti
atop
dermat
elev
total
specif
immunoglobulin
e
pathogen
mechan
owe
part
type
hypersensit
immedi
contrast
nonallerg
asthma
predomin
adult
rare
person
famili
histori
allergi
immunoglobulin
e
within
refer
valu
similarli
question
aris
role
play
differ
inflammatori
cell
implic
pathogenesi
take
exampl
univers
promin
eosinophil
differ
phenotyp
asthma
implic
actual
clinic
practic
lack
adequ
respons
inflammatori
action
glucocorticoid
patient
refractari
asthma
import
role
neutrophil
appear
perform
type
asthma
asthmat
situat
like
occup
asthma
virusinduc
exacerb
lifethreaten
suddenonset
asthma
believ
inflammatori
cell
combin
innat
immun
perform
relev
differenti
role
asthma
pathogenesi
simpl
academ
question
given
inflammatori
heterogen
known
today
asthmat
diseas
may
syndrom
rather
homogen
process
result
may
practic
repercuss
possibl
specif
treatment
futur
addit
acquir
immun
respons
asthma
well
characteris
involv
activ
lymphocyt
allergen
consequ
eosinophil
inflamm
airway
way
activ
eosinophil
secret
cytotox
granul
main
basic
protein
eosinophil
cation
protein
induc
bronchial
hyperrespons
consequ
symptom
patient
case
noneosinophil
asthma
subtyp
neutrophil
symptom
bronchial
hyperrespons
persist
spite
absenc
eosinophil
pathogen
mechan
well
characteris
howev
argument
implic
neutrophil
pathogenesi
would
kind
preprogram
respons
natur
immun
system
conserv
throughout
evolut
recent
studi
led
interest
expect
observ
neutrophil
asthma
increas
express
surfact
proteina
spa
activ
tlr
allergen
exampl
gener
cascad
signal
driven
activ
nuclear
transloc
nfkb
result
cytokinemedi
inflammatori
respons
e
like
allerg
asthma
nonallerg
asthma
exhibit
increas
eosinophil
cell
bronchial
mucu
develop
absenc
famili
person
histori
atopi
among
aetiolog
factor
noneosinophil
asthma
specul
unidentifi
allergen
autoimmun
bacteri
viral
infect
involv
nonallerg
asthma
often
associ
viral
rhinoviru
coronaviru
previou
bacteri
infect
could
mean
tlr
may
also
implic
clinic
form
asthma
develop
drug
act
tlr
centr
use
agonist
antagonist
ligand
agonist
molecul
bind
tlr
creat
respons
cell
antagonist
inhibit
bind
natur
agonist
ligand
consequ
caus
respons
possibl
role
divers
tlr
agonist
adjuv
vaccin
antimicrobi
treatment
antiallergi
treatment
cancer
current
evalu
along
structur
analogu
agonist
bind
receptor
induc
signal
cell
far
treatment
asthma
allerg
rhiniti
administr
cpg
oligodeoxynucleotid
cytosin
guanin
dinucleotid
drug
tlr
agonist
capabl
effect
prevent
revers
antigeninduc
bronchial
eosinophil
inflamm
anim
experiment
model
cpg
detect
b
lymphocyt
dendrit
cell
whose
ligand
activ
multipl
signal
cascad
respons
cell
lymphocyt
intracellular
compart
mainli
endosom
may
confer
greater
suscept
develop
diseas
asthma
rhiniti
atop
dermat
recent
observ
imiquimod
new
synthet
ligand
often
use
dermatolog
reduc
inflamm
bronchial
hyperrespons
concentr
total
immunoglobulin
e
blood
serum
cytokin
bronchioalveolar
lavag
attenu
express
transform
growth
factorbeta
remodel
airway
murin
model
acut
allerg
asthma
howev
spite
interest
advanc
knowledg
function
tlr
potenti
use
treatment
inflammatori
diseas
must
taken
account
number
inflammatori
cell
express
among
epitheli
cell
b
cell
mastocyt
eosinophil
condit
predict
concret
respons
tlr
agonist
antagonist
addit
like
microbi
product
gener
respons
contain
divers
ligand
variou
type
tlr
make
even
difficult
predict
possibl
favour
clinic
respons
around
third
world
popul
infect
mycobacterium
tuberculosi
littl
infect
immunocompet
develop
diseas
immunolog
mechan
distinguish
peopl
develop
tuberculosi
remain
unknown
genet
variat
tlr
individu
observ
among
polymorph
increas
suscept
pulmonari
tuberculosi
express
macrophag
increas
innocul
tuberculosi
vaccin
bcg
bacilo
calmetteguerin
divers
pathogen
chemic
agent
avian
influenza
sever
acut
respiratori
syndrom
identifi
caus
acut
respiratori
distress
syndrom
studi
perform
experiment
model
rat
acut
lung
injuri
ali
induc
acid
aspir
inactiv
influenza
viru
shown
mutat
confer
natur
resist
acut
pulmonari
damag
phospholipid
oxid
cytokin
product
macrophag
via
identifi
caus
ali
mutat
rat
demonstr
natur
resist
acut
pulmonari
damag
induc
ali
key
control
sever
ali
studi
rat
expos
hyperox
condit
attribut
relev
role
develop
acut
respiratori
distress
indic
absenc
hyperoxi
would
confer
protect
effect
said
effect
associ
induct
proapoptot
factor
pten
bid
affirm
pathway
import
role
induct
signal
associ
hyperox
pulmonari
injuri
cellular
death
vivo
vitro
genet
absenc
presenc
therefor
monoclon
antagonist
antibodi
appear
attenu
onset
well
amplif
hyperoxiainduc
pulmonari
injuri
favour
later
resolut
could
suggest
innat
immun
tlr
relev
role
pathogenesi
acut
pulmonari
injuri
antivir
action
nucleic
acidbas
agonist
activ
tlr
evalu
influenza
viru
infect
shown
express
dendrit
cell
respiratori
epithelia
macrophag
perform
central
role
mediat
innat
immun
inflammatori
respons
viral
infect
influenza
virus
may
inhibit
host
abil
produc
ifn
suppress
antivir
defenc
mechan
immun
system
evidenc
intranas
administr
rat
polyiclc
polyriboinosinicpolyribocytidyl
acid
liposomeencapsul
polyiclc
ifninduc
agonist
molecul
cytolyt
lymphocyt
confer
high
degre
protect
lethal
influenza
viru
protect
effect
last
week
liposomeencapsul
polyiclc
week
polyiclc
similarli
prior
treatment
mice
cpgoligonucleotid
agonist
confer
complet
protect
influenza
viru
understand
diseas
like
emphysema
necessari
know
mechan
allow
lung
maintain
structur
integr
constant
environment
aggress
tobacco
emphysema
characteris
gradual
loss
elast
lung
irrevers
enlarg
air
space
insuffl
entrap
gener
last
decad
life
relat
exposur
cigarett
smoke
although
smoke
cigarett
determin
risk
factor
associ
develop
copd
seriou
smoker
develop
suggest
influenc
condition
develop
pulmonari
emphysema
relat
host
mani
gene
implic
suscept
emphysema
specif
regul
macrophag
elastas
enzym
klotho
surfact
microsom
epoxid
hydrolas
nuclear
factor
erythroid
factor
oxidativeantioxid
proteaseantiproteas
imbal
may
caus
alter
observ
aforement
gene
precis
molecular
mechan
provid
maintain
oxid
proteas
balanc
still
unknown
studi
rat
shown
express
structur
cell
lung
necessari
maintain
normal
architectur
halt
oxid
stress
absenc
endotheli
cell
express
elev
concentr
intracellular
oxid
deriv
reduc
nicotinamid
adenin
dinucleotid
phosphat
nadph
oxidas
system
capabl
gener
inflammatori
respons
influenc
develop
copd
result
believ
act
suppressor
endogen
activ
lung
presenc
allow
pulmonari
integr
maintain
modul
said
oxid
system
receptor
perform
crucial
role
innat
acquir
immun
reason
molecul
activ
may
open
new
prevent
therapeut
strategi
allerg
chronic
obstruct
respiratori
diseas
human
alreadi
mention
express
monocyt
observ
diminish
significantli
patient
stabl
copd
healthi
smoker
suggest
perhap
innat
immun
respons
depress
patient
activ
alveolar
macrophag
epitheli
alveolar
cell
via
endotoxin
receptor
express
present
type
ii
pulmonari
epitheli
cell
may
also
perform
role
inflamm
airway
copd
product
activ
proinflammatori
mediat
furthermor
affirm
acut
exposur
cigarett
smoke
cigarett
twice
day
day
induc
acut
inflamm
rat
lung
signal
depend
smoke
pregnanc
also
describ
attenu
tlrmediat
immun
respons
probabl
increas
risk
child
develop
allergi
asthma
express
human
mastocyt
code
variat
also
thought
perform
relev
role
pathogenesi
copd
asthma
respiratori
epitheli
cell
fulfil
import
role
defenc
mechan
inflammatori
respons
host
current
treatment
bronchial
inflammatori
diseas
inhal
glucocorticoid
usual
drug
choic
effect
reduc
product
inflammatori
mediat
cytokin
chemokin
essenti
molecul
host
defenc
respons
effect
glucocorticoid
tlr
express
respiratori
epitheli
cell
studi
recent
found
express
increas
synerg
action
deriv
combin
glucocorticoid
dexamethason
effect
may
relat
glucocorticoid
receptor
sinc
action
dexamethason
abolish
antagonist
receptor
provid
glucocorticoid
anoth
new
benefici
function
addit
well
know
antiinflammatori
capabl
cystic
fibrosi
affect
airway
repres
environ
potenti
rich
tlr
agonist
chronic
inflammatori
phenotyp
evid
epitheli
cell
airway
also
perform
import
role
tlr
activ
significantli
greater
rise
express
affirm
patient
diseas
tlr
modul
current
evalu
possibl
therapeut
target
treatment
diseas
anoth
less
import
field
pneumolog
studi
mice
shown
low
volum
mechan
ventil
healthi
lung
induc
depend
inflammatori
respons
without
alter
integr
structur
lung
significantli
increas
endogen
ligand
bronchoalveolar
lavag
rel
express
messeng
rna
lung
tissu
circumst
may
open
expect
improv
knowledg
possibl
chang
immun
respons
experienc
ventil
patient
short
mani
experiment
studi
agre
tlr
import
role
defenc
mechan
immunoregul
evid
indic
possibl
alter
said
receptor
could
interven
inflammatori
pathogenesi
divers
respiratori
diseas
particularli
asthma
copd
infect
predict
greater
knowledg
molecul
empow
agonist
inhibit
antagonist
could
increas
therapeut
arsen
diseas
futur
varieti
clinic
trial
current
underway
differ
stage
develop
explor
effect
safeti
let
us
hope
futur
posit
expect
confirm
new
pharmacolog
treatment
avail
us
